Monday Dec 23, 2024
Monday Dec 23, 2024

acute myeloid leukaemia (AML)

Study finds immune therapy targets cells that cause leukemia relapse

Jun 3, 2022
Genetically engineered immune cells successfully targeted the specific cancer cells that may be responsible for relapse of acute myeloid leukaemia (AML)
Nepal's First Online News Portal
Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

Kathmandu, Nepal,


Newsroom
##

E-mail
nepalnewseditor@gmail.com

Terms of Use Disclaimer
© NepalNews. 2021 All rights reserved. | Nepal's First News Portal